Global Melanoma Drugs Market will reach USD 4.71 B

Sarasota, FL, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Melanoma Drugs Market by Therapy (Chemotherapy, Immunotherapy and Targeted Therapy) and Region: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2016 - 2022” . According to the report, global  melanoma drugs market  was valued at approximately USD 2.04 billion in 2016 and is expected to generate revenue of around USD 4.71 billion by end of 2022, growing at a CAGR of around 15.0% between 2016 and 2022. 

Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the skin and is most common because most pigment cells are found in the skin. Mucosal melanoma is melanoma of mucous membrane of the body, including the mouth, the nasal passages, the throat, the vagina or the anus. The rare ocular melanoma or uveal melanoma occurs in the eye.

Browse through 27 Market Tables and 14 Figures spread through 110 Pages and in-depth TOC on “Global Melanoma Drugs Market: By Type, Therapy, Size, Share, Trends, Segments, Analysis and Forecast 2016 – 2022”.

Request Free Sample copy of Melanoma Drugs Market Report @ https://www.zionmarketresearch.com/sample/mel...ugs-market

Global melanoma drugs market is primarily driven by growing incidences of target disease across the globe. Other major driving factors are the development of novel agents and combination therapy with lesser side effects and better survival. However, the high price of combination therapies and clinical trials coupled along with possible adverse events or side effects are the major restraints that may limit the growth of the market. Nonetheless increasing focus on personalized medicine coupled along with huge investment in anti-melanoma drugs research across the globe are likely to disclose the new avenues for melanoma drugs market in the near future.

The melanoma drugs market is segmented on the basis of the different therapeutic segment including chemotherapy, immunotherapy and targeted therapy. FDA approved immunotherapy agents such as pembrolizumab and nivolumab, which are under pipeline studies of many key players. Thus immunotherapy segment is expected to grow at the fastest rate during the forecast period.

Browse the full " Melanoma Drugs Market by Therapy (Chemotherapy, Immunotherapy and Targeted Therapy) and Region: Global Industry Perspective, Comprehensive   Analysis, and Forecast, 2016 - 2022 " report at  https://www.zionmarketresearch.com/report/mel...ugs-market

North America represents developed regional markets for melanoma drugs and is expected to see the rapid growth in the years to come. The U.S. is by far the leading melanoma drugs market by country in North America. The U.S. market is expected to grow at the highest CAGR during the forecast period. This growth is mainly due to the high prevalence of melanoma coupled with well-developed healthcare infrastructure and the increase in research and development on melanoma drugs. Moreover, the disposable income and reimbursement of life threatening diseases are very high in this region which promotes the growth of melanoma drugs market. 

Europe was the second largest regional market and is expected to show significant growth in the years to come. This growth is mainly due to increase in a number of patients diagnosed with melanoma and entry of novel therapies in the market.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/me...ugs-market

Asia-Pacific is expected to witness slow growth in the near future. This low growth is mainly attributed to the lower incidence rate of skin cancer in the Asian population. Thus Asia Pacific will slow-growing markets in melanoma drugs market.

In Middle East & Africa; African region is projected to register low growth rate due to lack of awareness and the high cost of melanoma drugs. Latin America is another important regional market and is expected to experience moderate growth over the forecast period. Thus, all the aforementioned parameters are expected to propel the market growth in this region.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/889

Some of the key players in Melanoma drugs market include Amgen, Bristol-Myers Squibb, Hoffmann-La Roche Ltd, Genentech Inc., Janssen Biotech, Inc., Novartis International AG., Pfizer, Sanofi, Takeda Pharmaceutical Company Limited and Teva Pharmaceuticals among others.

For more inquiry contact our sales team @ sales@zionmarketresearch.com

This report segments the global melanoma drugs market as follows:

Global Melanoma Drugs Market: Therapy Segment Analysis

• Chemotherapy
• Immunotherapy
• Targeted Therapy

Global Melanoma Drugs Market: Regional Segment Analysis

• North America
  • U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

Related Reports:

• General Anxiety Disorder Market: https://www.zionmarketresearch.com/report/gen...der-market
• Drug Discovery Informatics Market: https://www.zionmarketresearch.com/report/dru...ics-market
• Active Pharmaceutical Ingredients market: https://www.zionmarketresearch.com/report/act...nts-market
• Generic Drug Market: https://www.zionmarketresearch.com/report/gen...rug-market
• Veterinary Vaccine Market: https://www.zionmarketresearch.com/report/vet...ine-market
• Osteoporosis Drugs Market: https://www.zionmarketresearch.com/report/ost...ugs-market

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

Contact Us: Joel John 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States Tel: +49-322 210 92714 USA/Canada Toll-Free No.1-855-465-4651 Email: sales@zionmarketresearch.com Website: https://www.zionmarketresearch.com